================================================================================
                    CERTIFICATE OF INCORPORATION
                    COMPANY LIMITED BY SHARES
================================================================================

                    REGISTRAR OF COMPANIES
                    Maharashtra, Mumbai

--------------------------------------------------------------------------------

Certificate Number: U24230MH2012PLC234567

I hereby certify that BIOPHARMA INDUSTRIES LIMITED is this day incorporated
under the Companies Act, 1956 (No. 1 of 1956) and that the Company is Limited
by Shares.

Given under my hand at Mumbai this Fifteenth day of January Two Thousand and Twelve.

--------------------------------------------------------------------------------

COMPANY DETAILS:
----------------

Company Name:           BIOPHARMA INDUSTRIES LIMITED
CIN:                   U24230MH2012PLC234567
Registration Number:    234567
Date of Incorporation:  January 15, 2012
State:                 Maharashtra
RoC:                   RoC-Mumbai

Category:              Company Limited by Shares
Sub-Category:          Indian Non-Government Company
Class:                 Public Company

Authorized Capital:     Rs. 50,00,00,000 (Rupees Fifty Crores only)
Paid-up Capital:       Rs. 28,50,00,000 (Rupees Twenty Eight Crores Fifty Lakhs only)

--------------------------------------------------------------------------------

REGISTERED OFFICE ADDRESS:
-------------------------

BioPharma Industries Limited
Plot No. 234-235, MIDC Industrial Area
Thane-Belapur Road, Rabale
Thane - 400701
Maharashtra, India

Email: corporate@biopharma.com
Phone: +91-22-2568-XXXX
Fax: +91-22-2568-XXXX

--------------------------------------------------------------------------------

MAIN OBJECTS OF THE COMPANY:
---------------------------

The main objects to be pursued by the Company on its incorporation are:

1. To manufacture, produce, process, formulate, pack, import, export, buy,
   sell, trade and deal in all kinds of pharmaceutical preparations, medicines,
   drugs, tablets, capsules, syrups, injections, ointments, creams, lotions,
   and all other pharmaceutical and medicinal products and preparations in
   accordance with all applicable drug laws and regulations.

2. To manufacture and deal in Active Pharmaceutical Ingredients (APIs),
   intermediates, excipients, and all raw materials used in pharmaceutical
   manufacturing.

3. To obtain, apply for, maintain, and hold drug manufacturing licenses,
   import/export licenses, WHO-GMP certifications, US FDA registrations,
   EU GMP certifications, and all other regulatory approvals required for
   pharmaceutical manufacturing and trading.

4. To establish and maintain manufacturing facilities compliant with Schedule M
   of the Drugs and Cosmetics Rules and international Good Manufacturing
   Practice (GMP) standards.

5. To undertake research and development activities for new drug formulations,
   conduct bioequivalence studies, stability studies, and clinical trials in
   accordance with applicable regulations.

6. To register pharmaceutical products in India and foreign countries and to
   export pharmaceutical products to international markets.

--------------------------------------------------------------------------------

INCIDENTAL OR ANCILLARY OBJECTS:
-------------------------------

1. To acquire by purchase, lease, license or otherwise, land, buildings,
   manufacturing plants, machinery, equipment, patents, trademarks, copyrights,
   technical know-how and any other property, rights or interests.

2. To establish quality control laboratories, research and development centers,
   warehouses, and distribution facilities.

3. To enter into collaboration, joint venture, licensing, manufacturing, and
   distribution agreements with domestic and international pharmaceutical
   companies.

4. To borrow or raise money for the purposes of the Company by issue of
   debentures, bonds or other securities or by mortgage or charge.

5. To invest the funds of the Company not immediately required in such
   investments as may be determined from time to time.

--------------------------------------------------------------------------------

FIRST DIRECTORS:
---------------

1. Dr. Ramesh Narayan Kulkarni
   DIN: 00123456
   Designation: Managing Director
   Address: 45, Hiranandani Gardens, Powai, Mumbai - 400076

2. Mrs. Sunita Ramesh Kulkarni
   DIN: 00123457
   Designation: Whole-Time Director
   Address: 45, Hiranandani Gardens, Powai, Mumbai - 400076

3. Mr. Anil Shankar Joshi
   DIN: 00234567
   Designation: Director
   Address: 12, Raheja Residency, Thane West - 400601

--------------------------------------------------------------------------------

FIRST SUBSCRIBERS:
-----------------

1. Dr. Ramesh Narayan Kulkarni
   Shares Subscribed: 10,00,000 Equity Shares of Rs. 10/- each

2. Mrs. Sunita Ramesh Kulkarni
   Shares Subscribed: 5,00,000 Equity Shares of Rs. 10/- each

3. Mr. Anil Shankar Joshi
   Shares Subscribed: 5,00,000 Equity Shares of Rs. 10/- each

--------------------------------------------------------------------------------

                              [SEAL OF REGISTRAR]

                         Sd/-
                    Deputy Registrar of Companies
                    Maharashtra, Mumbai

Mailing Address for Registry:
Registrar of Companies, Maharashtra
100, Everest Building, Marine Lines
Mumbai - 400020

--------------------------------------------------------------------------------

NOTES:
-----

1. This Certificate is issued pursuant to Section 7 of the Companies Act, 2013
   (conversion from Companies Act, 1956).

2. The Company Registration Number and Corporate Identity Number (CIN) shall
   remain unchanged notwithstanding conversion to Companies Act, 2013.

3. Any person dealing with this Company should verify the current status of
   the Company and its Directors on the MCA Portal (www.mca.gov.in).

4. This Company is engaged in pharmaceutical manufacturing which is a regulated
   activity requiring drug manufacturing licenses from State Drug Authorities
   and compliance with Schedule M (GMP) requirements.

================================================================================
                         END OF CERTIFICATE
================================================================================
